
|
Report Date : |
03.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
NUTRI THERA
LABORATORY PRIVATE LIMITED |
|
|
|
|
Registered Office : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
13.05.1970 |
|
|
|
|
Com. Reg. No.: |
21-027725 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24232WB1970PTC027725 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
CALN00716C |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of
Health Care Products and Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Maximum Credit Limit : |
|
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an old
and established company having moderate track. Company’s profitability is under
severe pressure. It has some accumulated losses. Payments are reported as
slow but correct. The company can
be considered normal for small business dealings at usual trade terms and
conditions, with slight caution initially. |
LOCATIONS
|
Registered Office : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
Tel. No.: |
91-33-22406156 |
|
Mobile No.: |
|
|
Fax No.: |
91-33-22405579 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
27, Raicharan
Ghosh Lane, Kolkata – 700039, West Bengal, India |
|
Tel. No.: |
91-33-64503050 |
|
Fax No.: |
91-33-23430439 |
|
E-Mail : |
91-9830319740 |
|
Website : |
|
|
Area : |
18000 Sq. ft. |
|
|
|
|
Factory 2 : |
C/4, Sara
Industrial Estate, Dehradun – 2478197, Uttar Pradesh, India |
|
Tel. No.: |
91-33-22406156 |
|
Fax No.: |
91-33-22405579 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
35000 Sq. ft. |
SOLE
PROPRIETOR/PARTNERS/DIRECTORS
|
Name : |
Mr Dipankar Dutt |
|
Designation : |
Director |
|
Address : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
Date of Birth/Age : |
18.07.1954 |
|
Date of Appointment : |
30.09.1980 |
|
|
|
|
Name : |
Mrs Santi Dutt |
|
Designation : |
Director |
|
Address : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
Date of Birth/Age : |
20.09.1920 |
|
Date of Appointment : |
13.05.1970 |
|
|
|
|
Name : |
Mr Dipyaman Dutt |
|
Designation : |
Director |
|
Address : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
Date of Birth/Age : |
01.12.1982 |
|
Date of Appointment : |
29.11.2002 |
|
|
|
|
Name : |
Mr Ratnabali Dutt |
|
Designation : |
Director |
|
Address : |
P-19, Darga Road,
Kolkata – 700017, West Bengal, India |
|
Date of Appointment : |
31.08.2004 |
|
|
|
|
Name : |
Mr Kshiti Dutt |
|
Designation : |
Director |
|
Address : |
Mr Babu Ranjan
Guha |
|
Date of Birth/Age : |
Director |
|
|
|
|
Name : |
Mrs Lilabati Basu |
|
Designation : |
Director |
KEY EXECUTIVES
|
Name : |
Mr Dipankar Dutt |
|
Designation : |
Chief Executive
Officer / Manager |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders |
No. of Shares |
Percentage of
Holding |
|
Estate of Late K
R Dutt |
215 |
10.75 |
|
Mrs Santi Dutt |
515 |
25.75 |
|
Mrs Lilabati Basu |
1 |
0.00 |
|
Mr Dipankar Dutt |
1015 |
50.75 |
|
Mr Devjani
Huggings |
14 |
0.70 |
|
Mr Dipyaman Dutt |
140 |
7.00 |
|
Mr Ratnabali Dutt |
100 |
5.00 |
|
Total |
2000 |
100.00 |
|
|
|
|
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of
Health Care Products and Medicines |
|
|
|
|
Products : |
v
Veterinary
Medicines v
Oral Liquid v
Suspension v
Tablet v
Capsule v
Lotion & Ointment v
Bio-logical Products v
Chemical v Medicated
Foods and Food Products |
GENERAL
INFORMATION
|
No. of Employees : |
11-50 People |
|
|
|
|
Banking
Relations : |
|
|
|
|
|
Auditors : |
|
|
Name : |
S K Ganguli Chartered
Accountants |
|
Address : |
‘Sarobar’, Flat –
6NW, 102, Southern Avenue, Kolkata – 700029, West Bengal, India |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
2000 |
Equity Shares |
Rs 100/- each |
Rs 0.200 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
2000 |
Equity Shares |
Rs 100/- each |
Rs 0.200 Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
0.200 |
0.200 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
0.020 |
0.023 |
|
|
4] (Accumulated Losses) |
|
(0.511) |
(0.592) |
|
|
NETWORTH |
|
(0.291) |
(0.369) |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
5.891 |
0.574 |
|
|
2] Unsecured Loans |
|
0.000 |
0.000 |
|
|
TOTAL BORROWING |
|
5.891 |
0.574 |
|
|
DEFERRED TAX LIABILITIES |
|
0.073 |
0.051 |
|
|
|
|
|
|
|
|
TOTAL |
|
5.673 |
0.256 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
2.403 |
0.312 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
0.157 |
0.204 |
|
|
Sundry Debtors |
|
1.703 |
1.164 |
|
|
Cash & Bank Balances |
|
1.988 |
0.291 |
|
|
Other Current Assets |
|
0.000 |
0.000 |
|
|
Loans & Advances |
|
1.770 |
0.363 |
|
Total
Current Assets |
|
5.618 |
2.022 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
2.226 |
2.018 |
|
|
Provisions |
|
0.122 |
0.060 |
|
Total
Current Liabilities |
|
2.348 |
2.078 |
|
|
Net Current Assets |
|
3.270 |
(0.056) |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
5.673 |
0.256 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
|
|
Sales Turnover |
|
8.195 |
7.027 |
|
|
Total Income |
|
8.195 |
7.027 |
|
|
|
|
|
|
|
|
Profit/(Loss) After Tax |
|
0.165 |
0.024 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Interest |
|
0.049 |
0.000 |
|
|
Depreciation & Amortization |
|
0.061 |
0.059 |
|
|
Other Expenditure |
|
7.920 |
6.944 |
|
Total Expenditure |
|
8.030 |
7.003 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
|
2.01 |
0.34 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
(8.06) |
(5.63) |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
2.39 |
0.97 |
LOCAL AGENCY
FURTHER INFORMATION
From a humble beginning in 1970, journey through all these years has been a saga of honest effort and efficiency of labor.
Range of products is wide covering liquids, suspensions, ointments, lotions, tablets and capsules (non-beta lactum).
Kolkata factory is located on 18,000 sq. feet of factory space.
New factory coming up in Uttaranchal is of cGMP and WHO GMP standards, and has
an area of 35,000 square feet. Strict quality assuarance measures help us
ensure that company gives the best products to its customers. It is the
constant endeavour to keep up with the modern day technological developments in
the field of pharmaceuticals.
Manufacturing Sections :
Oral Liquid, Suspension, Tablet, Capsule, Lotion & Ointment
Quality Certification :
cGMP, WHO GMP, ISO
Joint venture partners sought for both technical and financial collaboration.
Company offers equity participation. Company can collaborate and manufacture
for exports branded generics (tablets/liquids/capsules) to other countries. The
intention is to create a new production facility in Kolkata, exclusively for
exports. Company’s associates are based in New York, USA.
Business
Subject is engaged
in the business of chemists, druggists, oilmen, importer and manufacturer of
and dealers in Pharmaceutical medicines including biological products, chemical
and other preparations including all types of preparations of medicated foods
and food products and to establish and carry on laboratory for the same.
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON DESIGNATED
PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government official
or a family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.59 |
|
UK Pound |
1 |
Rs.85.53 |
|
Euro |
1 |
Rs.58.14 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
2 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
-- |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
-- |
|
--CREDIT LINES |
1~10 |
1 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
22 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|